logo for Telix

Telix

Manufacturing · Australia · 415 Employees

View Company Info for Free

About

Headquarters

55 Flemington Rd Ste 401, North Melbourne, Vict...

Phone Number

+61 330933897

Revenue

$332.4 Million

Stock Symbol

TLX

Industry

Pharmaceuticals Healthcare

Highlights

$25M

Total Funding Amount

$25M

Most Recent Funding Amount

1

Number of Funding Rounds

Who is Telix

Telix Pharmaceuticals headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the United States.Read more

Telix's Social MediaPopular Searchestelix pharmaceuticals LtdTelix IncTelix PharmaceuticalsTelixTelix Industries IncSIC Code 28,283NAICS Code 32,325Ticker ASX: TLXShow more

Telix Org Chart

David Cade

Chief Executive Officer, Telix (Asia Pacific)

PhoneEmail
Darren Patti

Group Chief Operating Officer

PhoneEmail
Darren Smith

Group Chief Financial Officer

PhoneEmail

PhoneEmail

Similar Companies to Telix

  1. 329
    <$5M

    1

  2. 333
    $63.4M

    2

  3. 140
    $16M

    3

  4. 269
    $52.6M

    4

  5. 3,000
    $634M

    5

  6. 93
    <$5M

    6

See more similar companies

Telix Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateNov 02, 2020
RoundCorporate Investment
Amount$25M
InvestorsChina Grand Pharmaceutical and Healthcare Holdings Ltd.
See More

$25M

Total Funding Amount

$25M

Most Recent Funding Amount

1

Number of Funding Rounds

Acquisitions & Subsidiaries

Sep 03, 2021

QSAM Biosciences

Jan 24, 2018

ARTMS

Feb 23, 2014

Lightpoint Medical

Sep 17, 2013

ATLAB Pharma SAS

Nov 20, 2009

IsoTherapeutics Group

Dedicaid

See More Acquisitions & Subsidiaries

Telix Tech Stack

A closer look at the technologies used by Telix

Top Companies in Australia

Top 10 companies in Australia by revenue

Top 10 companies in Australia by number of employees

Top 10 companies in Australia by total funding amount

See top companies

Telix News & Media

  • Telix Announces Launch of Proposed Initial Public Offering in the United States

    MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (the “Company” or “Telix”) today announces the launch of its initial public offering in the United States (the “Offering”) of 17,000,000 American Depositary Shares (“ADSs”), each representing one ordinary share in Telix. The target size of the Offering is US$200 million in gross proceeds. In addition, Telix expects to grant the Underwriters (as defined below) a 30-day option to purchase up to an additional
  • Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging

    MELBOURNE, Australia, June 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET1 agent, TLX250-CDx (Zircaix™2, 89Zr-DFO-girentuximab), for the characterisation of renal masses as clear cell renal cell carcinoma (ccRCC).
  • Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer

    MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive data from the ProstACT SELECT trial (“SELECT”) of TLX591 (177Lu rosopatamab tetraxetan), a lutetium-labelled rADC therapy for the treatment of adult patients with PSMA-positive metastatic castrate-resistant prostate cancer (mCRPC). SELECT is a radiogenomics study intended to evaluate lesion concordance between 68Ga (gallium)-based PSMA-PET4 imagi
  • Telix Submits NDA for New Prostate Cancer Imaging Agent

    MELBOURNE, Australia, May 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for the preparation of PSMA-PET imaging[1] for prostate cancer. Subject to regulatory approval, this Kit will enable use of a PSMA imaging product with a considerably extended distribution profile compared to
Read more news

Frequently Asked Questions regarding Telix

Where is Telix located?
Telix's headquarters are located at 55 Flemington Rd Ste 401, North Melbourne, Victoria, 3051, Australia
What is Telix's phone number?
Telix's phone number is +61 330933897
What is Telix's stock symbol?
Telix's stock symbol is TLX
What is Telix's official website?
Telix's official website is www.telixpharma.com
What is Telix's Revenue?
Telix's revenue is $332.4 Million
What is Telix's SIC code?
Telix's SIC: 28,283
What is Telix's NAICS code?
Telix's NAICS: 32,325
How many employees does Telix have?
Telix has 415 employees
What industry does Telix belong to?
Telix is in the industry of: Pharmaceuticals, Healthcare
What is Telix competition?
Telix top competitors include: Antengene, George Clinical, Nucleus Network, Neuren Pharmaceuticals
What companies has Telix acquired?
Telix has acquired the companies: QSAM Biosciences, ARTMS, Lightpoint Medical, ATLAB Pharma SAS
What technology does Telix use?
Some of the popular technologies that Telix uses are: CommuniGator, DocuSign, WordPress.org, reCAPTCHA
Who is the CEO of Telix?
Telix's CEO is Kevin Richardson
Who is the CFO of Telix?
Telix's CFO is Harry Marfatia
How do I contact Telix?
Telix contact info: Phone number: +61 330933897 Website: www.telixpharma.com
What does Telix do?

Telix Pharmaceuticals headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the United States.... Read More

What are Telix social media links?
Telix Linkedin page Telix Twitter page Telix Facebook page
How much funding has Telix raised to date?
Telix has raised $25 Million in 1 funding round
When was the last funding round for Telix?
Telix closed its last funding round on Nov 02, 2020 with the amount of $25 Million
Is Telix a public company?
Yes, Telix is a public company and is traded under the symbol TLX
See more information about Telix

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.